Research workbench
Cid of human RPRD1B
Analyse Cid of human RPRD1B in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 4FU3
- Type
- protein
- Length
- 255 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Regulation of nuclear pre-mRNA domain-containing protein 1B
- UniProt
- Q9NQG5
- Ligands
- UNX, CL
- Pockets
- 2 · best druggability 0.58
Structure
x-ray diffraction · 2 distinct chains · 77% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Regulation of nuclear pre-mRNA domain-containing protein 1B | protein | 127 | 74% helix, 0% strand | Q9NQG5 |
| B | Regulation of nuclear pre-mRNA domain-containing protein 1B | protein | 128 | 80% helix, 0% strand | Q9NQG5 |
Ligands and binding sites
- UNX · Unknown atom or ion · ion · 10 copies · chains A, B
- CL · Chloride ion · ion · 3 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 82 | 0.58 | 0.87 | 20 | empty |
| 2 | 107 | 0.40 | 0.76 | 18 | empty |
Interfaces
1 interface between chains.
- A–B · 454 Ų buried · 7 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 modified (engineered).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9NQG5
- Elsewhere: RCSB PDB 4FU3 · PDBe 4FU3 · UniProt Q9NQG5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.